Search Results

QT Alterations in Psychopharmacology: Proven Candidates and Suspects

Authors: Alvarez, Paulino A.; Pahissa, Jaime

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 97-104(8)

Publisher: Bentham Science Publishers

Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation

Authors: Keller, Guillermo A.; Ponte, Marcelo L.; Di Girolamo, Guillermo

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 105-111(7)

Publisher: Bentham Science Publishers

Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment?

Author: Tsiouris, J. A.

Source: Journal of Intellectual Disability Research, Volume 54, Number 1, January 2010 , pp. 1-16(16)

Publisher: Blackwell Publishing

Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities

Authors: Oliver-Africano, P.; Dickens, S.; Ahmed, Z.; Bouras, N.; Cooray, S.; Deb, S.; Knapp, M.; Hare, M.; Meade, M.; Reece, B.; Bhaumik, S.; Harley, D.; Piachaud, J.; Regan, A.; Ade Thomas, D.; Karatela, S.; Rao, B.; Dzendrowskyj, T.; Lenôtre, L.; Watson, J.; Tyrer, P.

Source: Journal of Intellectual Disability Research, Volume 54, Number 1, January 2010 , pp. 17-25(9)

Publisher: Blackwell Publishing

Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis

Authors: Ma, Dan; Guest, Paul C; Bahn, Sabine

Source: Bioanalysis, Volume 1, Number 9, December 2009 , pp. 1615-1626(12)

Publisher: Future Science

Antipsychotic prescribing in nursing homes: an audit report

Author: Morrison, Anna

Source: Quality in Primary Care, Volume 17, Number 5, November 2009 , pp. 359-362(4)

Publisher: Radcliffe Publishing Ltd.

Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs: Implications in the Elderly

Authors: Vieweg, W. Victor R.; Wood, Mark A.; Fernandez, Antony; Beatty-Brooks, Mary; Hasnain, Mehrul; Pandurangi, Anand K.

Source: Drugs & Aging, Volume 26, Number 12, 1 December 2009 , pp. 997-1012(16)

Publisher: Adis International

Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I

Author: Miller, R.

Source: Current Neuropharmacology, Volume 7, Number 4, December 2009 , pp. 302-314(13)

Publisher: Bentham Science Publishers

Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART II

Author: Miller, R.

Source: Current Neuropharmacology, Volume 7, Number 4, December 2009 , pp. 315-330(16)

Publisher: Bentham Science Publishers

Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?

Author: Hashimoto, Kenji

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 470-474(5)

Publisher: Bentham Science Publishers

Sudden death in patients receiving drugs tending to prolong the QT interval

Authors: Jolly, Kate; Gammage, Michael D.; Cheng, Kar Keung; Bradburn, Peter; Banting, Miriam V.; Langman, Michael J. S.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 743-751(9)

Publisher: Blackwell Publishing

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II

Author: Zhou, Shu-Feng

Source: Clinical Pharmacokinetics, Volume 48, Number 12, 1 December 2009 , pp. 761-804(44)

Publisher: Adis International

Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

Authors: Aubry, Jean-Michel; Schwald, Michèle; Ballmann, Eladia; Karege, Félicien

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 419-429(11)

Publisher: Springer

Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study

Authors: Pouwels, S.; Staa, T.; Egberts, A.; Leufkens, H.; Cooper, C.; Vries, F.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1499-1506(8)

Publisher: Springer

Aggressive Behaviour in Adults with Intellectual Disability: Defining the Role of Drug Treatment

Authors: Oliver-Africano, Patricia; Murphy, Declan; Tyrer, Peter

Source: CNS Drugs, Volume 23, Number 11, 1 November 2009 , pp. 903-913(11)

Publisher: Adis International

Toxoplasma and schizophrenia

Authors: YOLKEN, R. H.; DICKERSON, F. B; FULLER TORREY, E.

Source: Parasite Immunology, Volume 31, Number 11, November 2009 , pp. 706-715(10)

Publisher: Blackwell Publishing

Effectiveness of Safety Warnings in Atypical Antipsychotic Drugs: An Interrupted Time-Series Analysis in Spain

Authors: Sanfélix-Gimeno, Gabriel; Cervera-Casino, Pedro; Peiró, Salvador; López-Valcarcel, Beatriz González; Blázquez, Amparo; Barbera, Teresa

Source: Drug Safety, Volume 32, Number 11, 1 November 2009 , pp. 1075-1087(13)

Publisher: Adis International

Applied psychometrics in clinical psychiatry: the pharmacopsychometric triangle

Author: Bech, P.

Source: Acta Psychiatrica Scandinavica, Volume 120, Number 5, November 2009 , pp. 400-409(10)

Publisher: Blackwell Publishing

Acupuncture for schizophrenia: a systematic review and meta-analysis

Authors: Lee, M. S.; Shin, B.-C.; Ronan, P.; Ernst, E.

Source: International Journal of Clinical Practice, Volume 63, Number 11, November 2009 , pp. 1622-1633(12)

Publisher: Blackwell Publishing

Risk of venous thromboembolism due to antipsychotic drug therapy

Authors: Hägg, Staffan; Jönsson, Anna K; Spigset, Olav

Source: Expert Opinion on Drug Safety, Volume 8, Number 5, September 2009 , pp. 537-547(11)

Publisher: Informa Healthcare